Cargando…
Adenovirus-Mediated Expression of the p14 Fusion-Associated Small Transmembrane Protein Promotes Cancer Cell Fusion and Apoptosis In Vitro but Does Not Provide Therapeutic Efficacy in a Xenograft Mouse Model of Cancer
Adenoviruses (Ads) are used in numerous preclinical and clinical studies for delivery of anti-cancer therapeutic genes. Unfortunately, Ad has a poor ability to distribute throughout a tumor mass after intratumoral injection, and infects cells primarily within the immediate area of the injection trac...
Autores principales: | Wong, Carmen M., Poulin, Kathy L., Tong, Grace, Christou, Carin, Kennedy, Michael A., Falls, Theresa, Bell, John C., Parks, Robin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795661/ https://www.ncbi.nlm.nih.gov/pubmed/26986751 http://dx.doi.org/10.1371/journal.pone.0151516 |
Ejemplares similares
-
Expression of the fusogenic p14 FAST protein from a replication-defective adenovirus vector does not provide a therapeutic benefit in an immunocompetent mouse model of cancer
por: Wong, C M, et al.
Publicado: (2016) -
Viral Membrane Fusion and the Transmembrane Domain
por: Barrett, Chelsea T., et al.
Publicado: (2020) -
Adenoviral Vectors Armed with Cell Fusion-Inducing Proteins as Anti-Cancer Agents
por: Del Papa, Joshua, et al.
Publicado: (2017) -
Nanodisc-cell fusion: control of fusion pore nucleation and lifetimes by SNARE protein transmembrane domains
por: Wu, Zhenyong, et al.
Publicado: (2016) -
Vesicular stomatitis virus G protein transmembrane region is crucial for the hemi-fusion to full fusion transition
por: Ci, Yali, et al.
Publicado: (2018)